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Abstract
Background: The global gene expression profiles of adult and fetal murine prostate stem cells were determined to define
common and unique regulators whose misexpression might play a role in the development of prostate cancer.
Methodology/Principal Findings: A distinctive core of transcriptional regulators common to both fetal and adult primitive
prostate cells was identified as well as molecules that are exclusive to each population. Elements common to fetal and adult
prostate stem cells include expression profiles of Wnt, Shh and other pathways identified in stem cells of other organs,
signatures of the aryl-hydrocarbon receptor, and up-regulation of components of the aldehyde dehydrogenase/retinoic acid
receptor axis. There is also a significant lipid metabolism signature, marked by overexpression of lipid metabolizing enzymes
and the presence of the binding motif for Srebp1. The fetal stem cell population, characterized by more rapid proliferation
and self-renewal, expresses regulators of the cell cycle, such as E2f, Nfy, Tead2 and Ap2, at elevated levels, while adult stem
cells show a signature in which TGF-b has a prominent role. Finally, comparison of the signatures of primitive prostate cells
with previously described profiles of human prostate tumors identified stem cell molecules and pathways with deregulated
expression in prostate tumors including chromatin modifiers and the oncogene, Erg.
Conclusions/Significance: Our data indicate that adult prostate stem or progenitor cells may acquire characteristics of self-
renewing primitive fetal prostate cells during oncogenesis and suggest that aberrant activation of components of prostate
stem cell pathways may contribute to the development of prostate tumors.
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Introduction
It is likely that the aberrant proliferation of prostate stem cells
(PSC) and/or their progenitors contributes to prostate pathology.
We determined the gene expression signatures of fetal and adult
PSC (FPSC and APSC) to gain insights into the signaling pathways
that characterize these two normal stem cell (SC) populations and
compared these profiles with those of prostate tumor cells.
Delineating these regulatory pathways may provide insight into
the mechanisms that convert quiescent adult prostate cells into a
proliferating compartment that gives rise to benign prostatic
hyperplasia and carcinoma thus permitting the targeting of specific
pathways to treat these diseases.
We have shown that epithelial cells with SC features are
concentrated in the proximal ductal region, adjacent to the
urethra [1–3]. These features include quiescence, high prolifera-
tive potential and the ability of single cells to give rise to ductal
structures that contain both basal and luminal cells [2–4]. We have
previously isolated, based on the expression of Sca-1 [2], two
populations of cells that are capable of regenerating prostatic tissue
in an in vivo prostate reconstitution assay. The first population,
stem cells, has considerable growth potential, does not require
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5722androgen for survival, expresses high levels of Sca-1 and resides in
the proximal region of ducts. Almost all Sca-1
Hi cells also express
/6 integrin, an antigen expressed on primitive prostate cells [2–4].
The second population, transit-amplifying cells, has more limited
growth potential, expresses lower levels of Sca-1, requires
androgen for survival and is found in all ductal regions [2,3]. A
third population, fetal prostate stem cells, exists in the urogenital
sinus from which the prostate develops [5]. The inner layer of
epithelial cells of the murine urogenital sinus starts invading the
outer layer of mesenchyme to form the ducts of the prostate gland
after E16. Prior to this event, the urogenital sinus epithelium
(UGE) containing primitive fetal prostate cells can be isolated
easily from the urogenital sinus.
In order to identify molecules and pathways that are active in
primitive prostate populations we determined the transcriptional
profiles of four populations of cells: (i) UGE, enriched in FPSC, (ii)
Sca-1
Hi, cells that express high levels of Sca-1, enriched in APSC
[2,6], (iii) Sca-1
Lo, cells that express medium to low levels of Sca-1
and are enriched in transit-amplifying cells [2], and (iv) Sca-1
Neg,
cells with no Sca-1 expression, that represent the most mature
population and have almost no regenerative potential [2]. To gain
insight into the regulatory layers of transcriptional networks active
in primitive prostate cells, we performed a computational screen of
cis-regulatory promoter motifs [7] to reveal those that are
significantly enriched among the PSC genes. We also identified
functional gene categories that are enriched in the primitive cells.
The fetal and adult SC populations expressed numerous known
SC-related genes. Our analysis revealed significant enrichment of
several transcription factor (TF)-binding site motifs in the
promoters of expressed genes. The data indicate that FPSC and
APSC have unique and common transcriptional programs and
identify a number of the key features that enable the maintenance
and self-renewal of the undifferentiated state. A number of the
stem cell-related genes we identify may also participate in the
development of prostate tumors, indicating that these molecules
may delineate a subset of tumors with a more primitive and
possibly a more aggressive phenotype.
Materials and Methods
Cell preparation, antibodies and FACS analysis
Ethics statement. All animal care and procedures were
performed in compliance with New York University institutional
review board requirements.
The proximal region of prostatic ducts (i.e., the portion of the
ducts nearest the urethra) of 6 week old C57BL/6 mice were
digested and cells were examined for antigen expression (Table
S1) [1,2]. Sca-1-labelled cells were sorted by FACS using a
DakoCyomation MoFlo sorter into 3 populations according to the
mean fluorescence intensity (MFI) of Sca-1 expression [2]. Cells
(10,000–50,000) with the highest MFI (25%; Sca-1
Hi), medium/
low MFI (40%; Sca-1
Lo) and those lacking Sca-1 expression (25%;
Sca-1
Neg) were collected in TRIzol (Invitrogen). UGE was isolated
from the urogenital sinus of 16-day-old C57BL/6 murine embryos
[8] and added to TRIzol. The expression levels of Aldh were
determined by FACS analysis after staining with the Aldefluor
reagent kit (StemCell Technologies).
Real-Time PCR
One mg of total RNA was reverse-transcribed at 52uC for
1 hour using the Thermoscript RT-PCR system (Invitrogen).
20 ng of resultant cDNA was used in a Q-PCR reaction using an
iCycler (Biorad) and pre-designed TaqMan Gene Expression
Assays (Applied Biosystems). Cycle threshold values from three
separate RNA samples were averaged; amounts of target were
interpolated from standard curves and normalized to hypoxan-
thine guanine phosphoribosyl transferase.
RNA isolation and microarray hybridization
We established transcriptional profiles for UGE, Sca-1
Hi,S c a - 1
Lo,
and for the Sca-1
Neg differentiated cells. Three replicates of UGE
(FPSC) and Sca-1
Hi (APSC) samples and four replicates of Sca-1
Lo
and Sca-1
Neg samples were analyzed. RNA was isolated by standard
procedures and its quality was assessed using an Agilent 2100
Bioanalyzer (Agilent Technologies). Samples with a RNA Integrity
Number (RIN) .7.0 were considered suitable for labeling and 20 ng
were labeled using the GeneChip two-cycle target labeling kit
(Affymetrix).Ten micrograms of labeled and fragmented cRNA were
then hybridized to the mouse genome MOE430 2.0 array
(Affymetrix) which interrogates ,45,000 transcripts. Raw expression
data (CEL files) were generated using GCOS 1.4 (Affymetrix). The
data discussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE15580 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE15580).
Analysis of gene expression data
Utilizing ArrayAssist (Stratagene), raw Affymetrix CEL files
were processed by applying the MAS5 algorithm, to assign
detection calls (Present/Marginal/Absent) for each probe set that
were subsequently used in downstream data filtering. To generate
normalized expression levels, we used PLIER (probe logarithmic
intensity error) algorithm, a model-based, multi-array signal
estimator which produces more accurate probe-set signal values
[9]. The combination of these above metrics was used for data
filtering to obtain 33,967 ‘‘valid genes’’, representing transcripts
(gene probes) with signals .20 and detected as Present in at least
one sample. To obtain a subset of variable genes, we calculated the
coefficient of variation (CV) for each transcript and generated a set
of 5095 ‘‘active genes’’ containing the transcripts with the highest
(15% of the total) CV scores. To focus on the genes that were
altered in a statistically significant manner, the samples were
grouped according to cell type (UGE, Sca-1
Hi, Sca-1
Lo, Sca-1
Neg),
intensities of the active gene transcripts were log2-transformed and
subjected to further statistical analyses utilizing two different tests:
(a) one-way ANOVA using a Benjamini-Hochberg correction
(p,0.05) and (b) significance analysis of microarrays (SAM)
method with a false discovery rate of 5%. This yielded a list of
3137 ‘‘significant genes’’, representing transcripts that matched the
criteria of both these statistical tests. A principle components
analysis (PCA) (mean centered) calculated by ArrayAssist, showed
an appropriate reproducibility and separation within the different
types of cells (Figure S1). To define the distinctive characteristics
of the UGE, Sca-1
Hi and Sca-1
Lo populations, we compared the
gene expression intensity reads (grouped samples) of each of these
populations with that of the most differentiated adult cells (Sca-
1
Neg) using an unpaired T-test (Benjamini-Hochberg corrected
p,0.05). Three gene subsets (UGE, Sca-1
Hi and Sca-1
Lo) that
contain transcripts whose expression increased (.1.75-fold)
relative to their expression in Sca-1
Neg cells were generated.
Analysis of functional categories
We utilized functional annotations of murine genes provided by
the Murine Genome Informatics, which uses the standard
vocabulary introduced by the Gene Ontology (GO) consortium.
Enriched functional categories (p#0.01, after correction for
multiple testing) were identified in each of the three clusters
Prostate Stem Cell Gene Study
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Hi, Sca-1
Hi-only) using EXPANDER, in
which hypergeometric calculation is used to determine over-
represented GO functional categories in a target set relative to a
background set (the entire collection of putative murine genes) [7].
To avoid biases, genes represented by multiple probe sets were
counted only once.
Computational analysis of promoter cis-regulatory
elements
For promoter analysis we applied EXPANDER [7] to detect cis-
regulatory promoter elements that control the observed transcrip-
tional alterations in the gene expression clusters. Given target and
background sets of promoters, EXPANDER performs statistical
tests to identify TFs whose binding-site signatures are significantly
over-represented in the target set relative to background (TF
enrichment is indicated by p-value) [7]. Both strands of each
promoter were scanned for putative binding sites (spanning the
transcriptional start site from 1000 bp upstream to 200 bp
downstream). The enrichments identified in this study were
robust, as they remained stable over a large range of threshold
values.
Comparison of data to known SC-profiles
Entrez Gene IDs and UniGene unique identifiers were used to
match genes represented in different microarray platforms. We
scored the number of genes that were commonly up-regulated in
the gene expression profiles and in at least one other SC profile.
Results and Discussion
Profiling of gene expression in three prostate stem/
progenitor cell enriched populations
RNA was isolated from the four cell populations described
above (UGE, Sca-1
Hi, Sca-1
Lo and Sca-1
Neg), prepared for
hybridization to microarrays and analyzed as described in
Materials and Methods. Three gene subsets (UGE, Sca-1
Hi, Sca-
1
Lo) were generated consisting of transcripts whose expression was
statistically elevated in each of the populations relative to their
expression in the most differentiated Sca-1
Neg cell population
(Figure 1, Table S2). The FPSC subset has the highest number
of significantly altered transcripts (1286 gene probes), as may be
expected when comparing a fetal SC with a differentiated adult
cell population. The APSC subset (Sca-1
Hi) has 641 and the
transit-amplifying subset (Sca-1
Lo; more differentiated than the
APSC subset) has only 144 transcripts that are differentially
expressed. We then determined whether we could discern
common expression patterns among these three progenitor subsets
and patterns that were unique to each subset. Intersection of the
up-regulated transcripts within the three subsets resulted in the
generation of four clusters (UGE-only, UGE+Sca-1
Hi, Sca-1
Hi-only,
Sca-1
Hi+Sca-1
Lo) of mutually or exclusively expressed genes
(Figure 1; Table S3). The most distinctive gene expression
pattern was derived from the UGE cell population, manifested by
1050 transcripts that were exclusively overexpressed in the UGE-
only cluster (FPSC cluster). A second distinctive pattern was evident
in the Sca-1
Hi subset, represented by the exclusive up-regulation of
296 transcripts in the Sca-1
Hi-only cluster (APSC cluster).
Interestingly, within the cluster that overlaps between the fetal
and the adult subsets, the UGE+Sca-1
Hi cluster, we found
substantial numbers of transcripts (209) that were commonly up-
regulated, while lesser commonality (112 transcripts) was observed
in the cluster that overlaps (Sca-1
Hi+Sca-1
Lo cluster) between the
APSC subset (Sca-1
Hi) and the TA subset (Sca-1
Lo)( Figure 1,
Table S2). Very few transcripts (5) were distinctively overex-
pressed in the more differentiated population (Sca-1
Lo-only cluster).
These results depict prominent stage-specific gene transcripts
expressed during the maturation of prostate cells, starting from the
most primitive fetal population (UGE), and progressing through
the APSC population (Sca-1
Hi), and its progeny, the transit-
amplifying cells (Sca-1
Lo), and culminating with the most
differentiated subset (Sca-1
Neg).
A. Expression of SC markers in prostatic stem/progenitor
clusters
Our profiling analysis indicates that all three stem/progenitor
enriched subsets contain substantial numbers of known markers of
murine PSC, namely Trp63, Cd200, Ctnnb1, Smo, Krt5, Krt14, Itga6/
Cd49f, Cd44, Kit, Bcl2, and Cd34 [10] (Figure 2A, B, Table S4).
A comparison of 11 known PSC markers that were up-regulated in
our subsets with a panel of 15 common murine housekeeping
genes, whose expression was not altered, confirms that our profiles
reflect a specific transcriptional signature of primitive FPSC and
APSC (Figure 2A; Table S4). In addition, transcripts for an
ephrin receptor, Ephb3, and two ephrin ligands, Efna5 and Efnb2,
which act as coordinators of migration and proliferation in the
intestinal SC niche [11] are up-regulated in both the FPSC and
APSC populations (Figure 2B). FACS analysis of Sca-1
Hi and
Sca-1
Lo cells validated the increased expression of several stem cell
antigens predicted by the microarray (Figure 3A) including stem
cell markers a6 and b4 –integrins [12], keratin 5, Bcl-2, b-catenin
[10], Sox2 [13] and CD34 [14] (Figure 3B). This indicates that
changes in mRNA levels of many SC-markers are reflected by
changes in their protein levels.
To determine if additional SC related genes were expressed in
the prostate stem/progenitor subsets, we used two approaches.
First, we utilized two bioinformatics tools (eGOn and FatiGO [15])
for identifying genes annotated as stem cell-genes based on prior
publications. This survey indicates that all our stem/progenitor-
related subsets (UGE, Sca-1
Hi, Sca-1
Lo) express a number of stem
cell markers (total of 67 genes) (Figure 2B; Table S5). Our
second approach for determining the primitive nature of the
profiles involved a systematic comparison of our profile with five
other gene expression profiles from embryonic (ESC), hematopoi-
etic (HSC), neuronal (NSC) [16,17], skin [18] and liver [19] stem
cells. We found that significant numbers of mRNAs expressed in
the prostate stem/progenitor clusters were also up-regulated in at
least one of the five published SC profiles (ranging from 40% of
the UGE-only mRNAs to 20% of the Sca-1
Hi+Sca-1
Lo mRNAs)
(Figure 2B, Tables 1, S6). Thus, despite the limitations of
comparing data obtained using different experimental conditions
and less comprehensive microarrays than used in our study, we
detected a high degree of overlap between genes overexpressed in
the prostate stem/progenitor profiles and those that are overex-
pressed in other SC profiles. This implies that prostate stem/
progenitor cells share numerous features with SC isolated from
other sources. However, prostate stem/progenitor cells also
express genes not identified in any of these five SC populations
indicating that some of these genes may be unique to prostate or
may be shared with other undescribed SC profiles. Notably, the
two approaches used for estimation of SC-marker enrichment
indicate that while there is considerable overrepresentation of SC-
related genes in adult Sca-1
Hi cells, there is an even higher
representation of SC-markers in UGE cells. Interestingly, a
comparison with two ‘stemness signature’ studies [16,17] indicates
that the PSC profile has greater overlap with ESC or NSC profiles,
than with HSC. For example, comparison with the data of
Ramalho-Santos et al [17] indicates that 14.4% and 16.1% of the
PSC-enriched mRNAs overlap with the ESC- and NSC-enriched
Prostate Stem Cell Gene Study
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5722Figure 1. Overlapping gene expression in primitive prostate cell populations. A Venn diagram detailing the number of transcripts (gene
probes) of overexpressed genes shared and distinct among UGE, Sca-1
Hi and Sca-1
Lo subsets. The number of transcripts within each subset is given in
brackets outside the Venn chart. The number of transcripts within each cluster is given in Italics inside the slices of Venn chart. Numbers of annotated
genes appearing in each of the four clusters are given in the inset table. The corresponding dendogram of each cluster is presented.
doi:10.1371/journal.pone.0005722.g001
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PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5722mRNAs respectively, whereas fewer mRNAs (6.8%) overlap with
HSC-enriched transcripts (Table 1). Several recent studies have
shown that gene expression profiles of ESCs and NSCs overlap
with each other to a greater extent than with HSC [17,20].
Accordingly, our results suggest that the prostate progenitor
lineage may resemble that of neuronal or embryonal progenitors
to a greater extent than that of hematopoietic progenitors.
The presence of significant numbers of SC genes in our APSC
and FPSC suggests that these populations have the characteristics
of undifferentiated progenitor cells. We next determined the
Figure 2. Known markers of primitive prostate (A) and stem (B) cells are expressed. A. Expression profiles of molecules described as being
expressed in primitive prostate populations that were up-regulated at least 2-fold (upper panel) in the UGE, Sca-1
Hi and Sca-1
Lo cells are presented.
Each column represents an individual sample, and each row represents a specific gene. Red (high), green (low) relative expression; black indicates
equal expression relative to the Sca-1
Neg cells. The lower panel presents a cassette of 15 common murine housekeeping genes that manifest stable
expression across all samples. Log ratio (LR) values are presented in Table S3. B. Expression profiles of known SC markers (eGOn and FatiGO survey),
that were up-regulated by at least 2-fold in prostate stem/progenitor enriched samples. Five expression patterns can be distinguished. LR values are
presented in Table S5.
doi:10.1371/journal.pone.0005722.g002
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5722Figure 3. Transcript and protein expression of SC markers in primitive (UGE, Sca-1
Hi) and progenitor (Sca-1
Lo) cells. A. Transcription
level of SC markers in primitive and progenitor prostate cells. Microarray data of SC markers from these primitive cell populations are expressed as LR
values [mean6SD] relative to mature Sca-1
Neg samples. B. Antigen expression of SC markers on Sca-1
Hi and Sca-1
Lo cells. FACS analysis of Sca-1
Hi and
Sca-1
Lo cells determined the expression of SC markers (denoted in A) on these populations. Enrichment values [mean6SD] are expressed as the fold
change in antigen expression relative to the antigen expression of the mature Sca-1
Neg cell population.
doi:10.1371/journal.pone.0005722.g003
Prostate Stem Cell Gene Study
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potential signaling pathways that are expressed by these cells.
B. Identification of overrepresented functional categories
and TF-binding promoter motifs within the clusters of
genes that are overexpressed in the stem/progenitor
cells
To identify the major biological processes and transcriptional
networks within the three SC-containing clusters (UGE-only,
UGE+Sca-1
Hi, Sca-1
Hi-only; Figure 1) we applied the EXPANDER
package for functional and promoter analysis. A number of
functional categories and TF-binding promoter motifs are
significantly enriched in these clusters (Tables 2, S7).
a) Self-renewal signature in FPSC
The UGE-only cluster is highly enriched in cell proliferation
genes , as would be expected for an expanding fetal population
(Tables 3, S7,8). Up-regulation of Mki67 (12-fold) exclusively in
the UGE subset attests that these cells are proliferating.
Proliferation and cell cycle-related pathways are elevated in the
self-renewal of normal SC [21]. PTEN deletion, which enlarges
the pool of self-renewing NSC [21], reveals a SC-self-renewal
signature (231 genes) for these cells. Notably, approximately 64%
of these genes are also up-regulated in the UGE-only cluster,
indicating considerable similarity in gene expression between these
two self-renewing populations (Table S9). Components, as well as
target genes, of the Wnt/b-catenin pathway that promotes self-
renewal in many types of SC [22] are strongly represented in
FPSC and APSC (Tables 3, S10). The aberrant activation of this
pathway in prostate tumors [23] and its enrichment in PSC is
consistent with the notion that prostate cancer may arise in the
primitive compartment. qPCR analysis validated the gene
expression profiles, indicating that expression of Wnt4 is elevated
in FPSC (5-fold ) and APSC (8-fold) relative to mature cells (Sca-
1
Neg). In addition, Wnt6 is elevated in FPSC (22-fold), and Fzd6 is
elevated in FPSC (5-fold) and APSC (3-fold) relative to mature
cells (Table S11). Components of the sonic hedgehog (Shh)
pathway, which is also implicated in the self-renewal of primitive
cells [24] and the suppression of differentiation, are manifest in
FPSC and APSC (Tables 3, S12). The abundance of Shh-
regulators and target genes that are up-regulated in the FPSC and
APSC indicates that autocrine hedgehog signaling may play an
important role in prostate progenitor/stem cell biology. qPCR
analysis validates the gene expression data and indicates that Shh
and Gli3 expression are increased in fetal (35-fold and 4-fold
respectively) and adult (6-fold and 3-fold respectively) SC relative
to mature cells (Table S11). Hedgehog signaling is important for
normal prostate growth and increases during prostate tumorigen-
esis in concert with an increase in progenitor cell markers [25],
implying again that primitive cells may be expanded during
tumorigenesis.
TF-binding site analysis of promoters for genes that were up-
regulated within the FPSC (the UGE-only cluster) identifies two
transcriptional regulators of the cell cycle, namely E2f and Nfy
(Tables 2, S13), consistent with over-representation of self-
renewal genes (Tables 3, S7) [20]. Importantly, increases in the
levels of mRNAs encoding four members of the E2f family are
observed along with numerous genes that are specific targets of
E2f3 (Table 3). Analysis by qPCR confirms that E2f3 (3-fold) and
its representative target gene, Cdc2a (12-fold), are up-regulated in
the UGE cells compared with mature cells (Table S11).
Interestingly, E2f3 expression is associated with the self-renewal
of murine trophoblast SC [26], the expansion of SC in the
columella and lateral root caps of Arabidopsis [27], and a poor
prognosis in prostate cancer [28]. The binding-motif signature for
Nfy is also well represented in the promoters of FPSC genes and is
in accordance with the increased transcription of Nfya and Nfyb
subunits and the finding that Nfya is a potent inducer of HSC self-
renewal [29].
Additional promoter signatures that are enriched in the UGE-
only cluster are those of Ap2 and of the embryonic TEA domain-
containing factor (ETF), also known as Tead2 (Tables 2, S13). In
the FPSC expression of ETF/Tead2 and its coactivator, Yap1, were
increased by 4- and 2- fold respectively. The increased expression
of Tead2 (4-fold) in FPSC relative to mature cells was verified by
Table 2. Promoter analysis of primitive prostate clusters.
Cluster TF
Accession number
in TRANSFAC DB p-value* Enrichment Factor**
UGE-only (FPSC) E2f M00918 4.7E-14 1.92
Nfy M00287 4.9E-14 1.63
ETF/Tead2 M00695 1.2E-09 1.44
Ap2 M00189 1.5E-05 1.29
AhR/Arnt M00235 1.1E-03 1.32
UGE+Sca-1Hi (FPSC and APSC) Srebp1 M00749 5.5E-04 1.66
Ap2 M00189 4.9E-03 1.31
Smad3 M00701 5.2E-03 1.76
Fxr/Rxra M00631 7.3E-03 2.00
Sca-1Hi-only (APSC) Smad M00974 2.8E-03 1.80
Srebp1 M00221 8.6E-03 1.59
T3r (Rxr-a or b) M00963 1.1E-02 1.73
Smad3 M00701 2.2E-02 1.54
TFs whose binding site profiles were significantly enriched in the three SC-related clusters described in Fig. 1 are presented.
*P values indicate the significance of TF signature enrichment in the cluster relative to that in the background set as described in Materials and Methods.
**Enrichment factor values represent the frequency of the TF signature in a cluster divided by its frequency in the background set.
doi:10.1371/journal.pone.0005722.t002
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renewal of progenitor cells in the olfactory epithelium [30] and is
essential during murine embryo development [31]. Ap2 transcripts
are elevated 3-fold and a number of its target genes are increased
(Table 3). Ap2 promotes proliferation over differentiation and is a
marker of SC and pluripotency [32]. Thus, E2f, Nfy, Tead2 and
Ap2 are likely to be involved in the self-renewal and expansion of
the primitive prostate population.
b) TGF-ß signaling signature in APSC
In contrast to the abundance of proliferation genes present in
the expanding UGE population, in APSC (Sca-1
Hi subset) we find
that TGF-b target genes are upregulated indicating that TGF-b
signaling is a prominent feature of APSC. We previously
documented that the maintenance of dormancy of APSC is
dependent on the TGF-b/Smad2/3 signaling pathway [33].
Significantly, our cis-element promoter analysis identifies enriched
binding-sites for Smad and Smad3 in the Sca-1
Hi-only cluster, while
similar sites were absent from the UGE-only cluster (Table 2),
indicating that TGF-b/Smad signaling may have a predominant
role in APSC.
The expression level of Itgb6, an integrin that binds and
activates TGF-b [34] is up-regulated 3-fold in APSC (Table 3). In
addition, an increase in the expression levels of Igfbp3 (14-fold),
that phosphorylates Smad3 [35], is observed exclusively in the
Sca-1
Hi subset. Validation by qPCR (3-fold; Table S11) and
FACS analysis (3-fold; Figure 3B) confirms that the TGF-b target
gene clusterin (Clu) is up-regulated in APSC. Our promoter
analysis also identifies overrepresentation of the SMAD3 motif in
the promoters of genes from the UGE+Sca-1
Hi cluster (Table 2),
indicating that TGF-b may also mediate signaling in the FPSC. As
a second approach for determining the possible involvement of
Table 3. Transcriptional profile of genes expressed in (i) UGE, (ii) in both UGE and Sca-1Hi and (iii) Sca-1Hi subsets relative to the
Sca-1Neg subset.
Subset Category mRNAs
UGE (FPSC) Cell cycle Cdc2a (x10)*, E2f3 (x3), Tead2 (x4), Cdc25c (x4), Cdkn3 (x3), Cdk4 (x7), Mcm2
(x5), Mcm6 (x7), Nras (x5), Ccna2 (x9) , Ccne1 (x53), Brca1 (x4), Mki67 (x12)
Chromatin modifiers Ezh2 (x9), Hdac2 (x3), Bmi1 (x2), Jarid1b (x5), Hmga1 (x11), Hmga2 (x47), Suv39h2
(x4), Dnmt3a (x4)
Notch signaling Lfng (x4), Dll1 (x2) Sdcbp2 (x3)
E2f-target genes Cdc2a (x10), Cdc6 (x7), Ccne1 (x52), Dhfr (x5), Mcm2 (x4), Mcm5 (x8), Mcm6 (x6),
Orc1l (x9), Tk1 (x4), Tyms (x5), Ccna2 (x9)**, Cdca3 (x6)**, Igf2 (x28)**, Mad2l1 (x5)**,
Mal2 (x10)**, Rrm2 (x4)**, Tpx2 (x10)**, Ube2c (x5)**, Plk1 (x9)**
Nfy-target genes Ccnb1 (x12), Ccnb2 (x8), Plk1 (x9), Cdc25c (x2), Ccna2 (x9), Col11a1 (x5), Cdc2a
(x10), Hes1 (x2), Tert (x3)
Ap2-target genes Igf2 (x27), Lor (x28), Cdh1 (x3), Erbb2 (x2)
UGE and Sca-1Hi (FPSC
and APSC)
Shh signaling Shh (x7, x4), Gli3 (x7,NC), Mycn (x82, x2), Hhat (x2, NC), Disp1 (x2, NC), Sufu (x2,
NC), Smo (x3, NC), Chek (x8, NC), Ptch1 (x2, NC)
Wnt Signaling Wnt4 (x9, x5), Wnt6 (x8, NC), Fzd6 (x8, x3), Ctnnb1 (x2, NC), Wnt7a (x37, NC),
Csnk1g1 (x2, NC), Fzd2 (x3, x-2), Fzd3 (x2, NC), Wnt7b (x4, x2), Wnt9b (x4, NC),
Wnt10a (x14, x4), Lrp6 (x2, x3)
Ahr pathway and target genes Ahr (x4, x5), Tk1 (x5, NC), Syt9 (x17, NC), Cd1d1 (x9, NC), Arnt2 (x5, NC), Smad3 (x5,
NC), Magi3 (x4, NC), S100g (x4, NC), Snn (x6, NC), Col11a1 (x5, NC), Mycl1 (x5, NC),
Slc2a1 (x5, NC), Lamb3 (x3, x6), Zfp36l1 (x2, x2), Sprr1a (x21, x21), Cdh3 (x5, x2)
ALDH/RA/Retinoid recepror axis Aldh1a2 (x4, x -7)***, Rxra (x4, NC), Rarg (x2, x3), Rarb (x6, NC), Crabp2
(x15, NC), Aldh1a3 (x7, x2), Aldh1a7 (x4, x4), Aldh3a1 (x -7, x6), Aldh3b2 (x4, NC)
Epithelial morphogenesis factors Krt4 (x28, x28), Krt6a (x16, x2), Alcam (x5, x2), Efna5 (x9, x2), Efnb2 (x9, x3), Ephb3
(x7, x3), Celsr1 (x18, x4), Evpl (x10, x4), Ppl (x11, x6)
Phospholipid metabolism Rxra (x4, NC), Pltp (x2, x8), Akp2 (x2, x2), Lypd2 (x23, x3), Lypd3 (x25, x2), Anxa8
(x8, x6), Lgals3 (x3, x8), Dlk1 (x9, x2), Ly6a (x-2, x18), Tiam1 (x12, x3), Fasn (x2, NC),
Hmgcr (x4, NC)
TGFb-pathway and target genes Clu (x-4, x4), Mmp11 (x8, NC), Smad2 (x2, NC), Smad3 (x3, NC), Lrp1 (x3, x5), Klf4 (x-
4, x4), Eng (NC, x4), Junb (x-5, x3), Acvrl1 (NC, x3), Rhoa (NC, x4), Itgfbp3 (NC, x14),
Itgb6 (NC, x3)
Detoxification and protection from
oxidative stress
Ahr (x4, x5), Aldh1a2 (x4, x -7), Aldh1a3 (x7, x2), Aldh1a7 (x4, x4), Ahr (x4, x5),
Cyp2s1 (x2, x4), Cyp2c29 (x2, x3), Cyp51 (x2, NC), Cyp4f39 (x37, NC), Cyp26b1 (NC,
x2)
ABC transporters Abcb1a (x-3, x18 ), Abcd3 (NC, x3), Abcc3 (NC, x3), Abcc4 (x4, x4 ), Abcc5 (NC, x2)
Sca-1Hi (APSC) Calcium dependent regulators Thbd (x12), Itpr3 (x2), Anxa3 (x6), S100s10 (x22), Cacna2d4 (x3), Trpc2 (x2),
Cbara1 (x6), Ryr2 (-5), Ryr3 (x-3), Itpr2 (x2),
Functional classification is shown for 146 mRNAs scored as increased relative to differentiated Sca-1Neg cells (Table S3). The average relative increases (fold change)
from three comparisons is given in parentheses. When two values are presented in brackets following a gene, the first number represents the fold change in UGE, the
second in Sca-1Hi. A mRNA that is present but not increased is denoted NC.
*Bolded genes represent those that were validated by FACS or qPCR.
**Specific E2f3-target genes.
***Aldh activity is elevated in Sca-1Hi cells (Figure 3B).
doi:10.1371/journal.pone.0005722.t003
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genes from the three SC-enriched clusters (UGE-only, UGE+Sca-1
Hi
and Sca-1
Hi–only) with the TGF-b-driven signature from keratino-
cytes [36]. These comparisons indicate that approximately 14% of
the genes in each of these three tested clusters may be TGF-b
targets (UGE-only 112/823; UGE+Sca-1
Hi 19/130; Sca-1
Hi–only 23/
172 genes) (Table S14), supporting the contribution of TGF-b
signaling in FPSC in addition to its prominent role in the APSC
(Table 3). In this regard it is important to note that Smad2 and
Smad3, the two main transcriptional mediators of TGF-b, are
exclusively up-regulated in the UGE (Table 3). The prominent
representation of the Smad binding-site motif in the promoters of
genes that are up-regulated in the APSC (Sca-1
Hi-only cluster)
indicates that the TGF-b signaling pathway is highly relevant to
the transcriptional program of these cells and supports the finding
that TGF-b maintains the quiescence of APSC [33]. In FPSC the
inhibitory effects of TGF-b may be negated by the expression of
numerous molecules related to self-renewal (see above). It is also
possible that TGF-b may have a different function in primitive
fetal prostate cells and that it may promote their self-renewal and
maintenance as has been shown in embryonic cells [37]. In
summary, we find that FPSC express many regulators that
participate in self-renewal as expected in a developing fetal organ.
In contrast, target genes of the TGF-b signaling pathway, which
maintains dormancy in the adult prostate stem cell niche [33] are
significant features of APSC.
c) The Ahr/Arnt pathway is expressed in fetal and adult
PSC
The aryl-hydrocarbon receptor (Ahr)/Ahr receptor nuclear
translocator (Arnt) pathway has important roles in organ
development and dioxin toxicology and may be essential for
protection against oxidative stress [38]. As the importance of Ahr
in prostate biology is well documented and its deficiency results in
a smaller prostate [39] and in increased susceptibility to prostate
tumors [40], it is of interest that the binding site of this TF is
overrepresented in the promoters of genes of the UGE-only cluster
(Table 2). Microarray data (Tables 3, S13) and qPCR analysis
(FPSC 2-fold; APSC 3-fold; Table S11) both indicate that Ahr and
many of its target genes are up-regulated in FPSC and APSC,
implying that the Ahr/Arnt complex is transcriptionally active in
PSC. Exposure of mice to the Ahr agonist, dioxin, increases the
absolute number of bone marrow SC [41], but, surprisingly, these
cells are deficient in self-renewal and have impaired regenerative
potential [42]. Similar to its effects on HSC, dioxin also inhibits
fetal prostatic bud formation [43]. As Ahr/Arnt promoter binding
sites are enriched in the genes of the UGE subset, we propose that
Ahr is necessary for the regulation of PSC activity and that its over
activation may impair self-renewal and the subsequent expansion
and differentiation of prostate progenitor cells.
d) The Aldh/RA/retinoid receptor axis is expressed in PSC
An interesting category of genes up-regulated in the UGE-only
cluster is that related to embryonic development (Table S7). This
includes two aldehyde dehydrogenase (Aldh) enzymes, Aldh1a2
and Aldh1a3 (Table S8), which convert retinal into retinoic acid
(RA) [44], a critical factor promoting differentiation. In addition,
expression of Crabp2 that shuttles RA into the nucleus to bind RA
receptors [45], is exclusively up-regulated in the UGE (15-fold)
(Table 3) and is confirmed by qPCR analysis (47-fold; Table
S11). Other Aldh isoforms are also increased in either both or one
of the primitive populations including Aldh3b2, Aldh1a7 and
Aldh3a1 (Table 3) and Aldh activity is increased in APSC (10-
fold) (Figure 3B). High levels of Aldh are present in hematopoi-
etic and neural SC [46–49].
Our promoter analysis supports the notion that retinoid
receptors may participate in the transcriptional program of
primitive prostate cells, as both the UGE+Sca-1
Hi and the Sca-
1
Hi-only clusters are enriched in the signature of the retinoid
heterodimer receptor, Rxr (Tables 2, S13). Additionally, the
nuclear receptor Rxra and two of its binding partners, Rarb and
Rarg, are up-regulated in FPSC (Table 3). qPCR analysis confirms
elevation of Rxra in FPSC (4-fold) and APSC (3-fold), Rarb in FPSC
(3-fold) and APSC (2-fold) and Rarg in APSC (3-fold) (Table S11).
Thus, a number of the major regulators of the RA/retinoid
receptor axis are elevated in FPSC and APSC and their expression
in PSC may reflect a ‘tipping-point’ beyond which these cells
embark on a differentiation-induced program.
e) A lipid metabolism signature is evident in FPSC and
APSC
Our data indicate that genes related to phospholipid metabo-
lism are up-regulated in the UGE+Sca-1
Hi cluster (Table S7),
including SC niche-related genes such as Tiam1 [50] and self-
renewal genes such as Akp2 [51] (Table 3). Recent evidence
demonstrates the importance of lipids in the self-renewal of SC
[52,53]. Interestingly, the retinoid heterodimer receptor (Fxr/Rxr)
complex, whose binding motif is enriched in the promoters of the
genes of the UGE+Sca-1
Hi cluster (Table 2), is also implicated in
the regulation of lipid metabolism [54]. A critical phospholipid
transporter, Mdr3/Abcb1a, whose expression is up-regulated by
FXR [55], is also up-regulated in APSC (Table 3) as well as
several ABC-transporters that are relevant in phospholipid
metabolism and that identify SC (Table 3). The binding motif
of sterol regulatory element-binding factor 1 (Srebp1), an
androgen-regulated TF with a role in the metabolism of lipids
[56], is enriched in genes of the UGE+Sca-1
Hi and the Sca-1
Hi-only
clusters (Table 2). Several Srebp1 lipid metabolizing target genes
(Lgals and Dlk1) are up-regulated in FPSC and APSC (Tables 3,
S13). Increased expression of Pltp, another Srebp1-target gene, in
the FPSC (2-fold) and APSC (8-fold) is confirmed by qPCR
(Table S11). Srebp1 promotes the transcription of HMG-CoA
reductase (Hmgcr) and fatty acid synthase (Fasn). HMG-CoA
reductase, an enzyme that catalyzes the conversion of HMG-CoA
to mevalonate, a precursor of cholesterol [57], is up-regulated 4-
fold, and Fasn is up-regulated 2-fold in FPSC (Table 3).
Interestingly, Srebp1 contributes to the androgen-independent
survival and proliferation of prostate cancer cells [58], indicating
that lipid metabolism may be relevant to both normal stem and
prostate tumor cell biology. In this regard, it is important to note
that lipid metabolism in prostate stem cells may not only be
relevant for stemness features but may also have an important role
in the production of androgens. Prostate tumors have the innate
capacity to synthesize their own androgens from cholesterol [59].
In summary, we show that a significant number of factors that
regulate lipid homeostasis and are important in SC biology are up-
regulated in primitive prostate cells.
C. Commonalities are evident in the signatures of murine
PSC and human prostate cancer
Both prostate carcinoma and benign prostatic hypertrophy are
considered to arise from the aberrant proliferation of prostate stem
cells. As tumors may express proteins present in their correspond-
ing fetal or primitive adult tissues, an understanding of molecules
and pathways expressed by primitive prostate populations may
contribute significantly to the development of new therapeutics for
Prostate Stem Cell Gene Study
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signatures and cancer signatures has been shown for human
hepatocellular carcinoma where the fetal rodent SC signature has
prognostic significance for human hepatocellular carcinoma [60].
To determine if genes were expressed in common in murine PSC
and human prostate tumors, the signature of murine PSC was
compared to the signature of human prostate tumors [61]. For this
purpose, gene expression data generated by a screen that
compared normal human prostate specimens with primary
prostate tumors [61] were used (two-group t-test (p,0.05)). This
generated two lists of genes: (i) genes that were up-regulated, and
(ii) genes that were down-regulated in human prostate tumors.
Next, our up-regulated murine PSC profiles were compared with
these two lists of genes.
Of the genes expressed in the UGE-only cluster, 64 were up-
regulated in tumors compared to normal human samples (Table
S15). Among the PSC-related genes that were up-regulated in
tumors are several cell cycle genes (e.g., Mcm2, Cdc6, and Pole).
FPSC also express high levels of N-Ras mRNA (4-fold increase),
an oncogene that is associated with the development of hormone
refractory prostate cancer [62]. Another gene that is up-regulated
(2-fold) in FPSC and whose expression is correlated with the
progression and aggressiveness of prostate cancer, is fatty acid
synthase (Fasn), an enzyme with a major role lipid metabolism [63].
One of the genes that catalyzes the conversion of testosterone into
the more potent androgen, dihydrotestosterone, Sra5a1, is up-
regulated (8-fold) in the FPSC. This gene may be associated with
the progression of prostatic tumors to androgen insensitivity as its
transcripts were absent from metastatic prostate lesions but present
in primary prostate tumors [64]. Importantly, our PSC profiling
also indicates that expression of Hdac2 is increased in FPSC
(Table 3). The elevated expression of this enzyme, associated with
epigenetic alterations, is correlated with diminished relapse-free
survival in prostate cancer [65]. Additionally, numerous chroma-
tin modifiers that promote the cell cycle and prostate tumor
progression, including Ezh2 [66], Bmi1 [67], Jarid1b [68], Hmga1
[69], Hmga2 [70], Dnmt1, Dnmt3a [71] and Suv39h2 are up-
regulated in FPSC (Table 3). qPCR analysis confirms increased
expression of Ezh2 (4-fold) in FPSC (Table S11). Among the 56
PSC-related genes that are down-regulated in prostate tumors are
Rarb and Crabp2, two mediators of the RA pathway. Decreased
expression of these molecules may result in expansion of primitive
tumorgenic cells by preventing differentiation. Another PSC-
related gene that is down-regulated in prostate tumors is Smad3,
whose reduced expression may result in proliferation as the
inhibitory influence of TGF-b is reduced [33].
Among the genes present in the UGE+Sca-1
Hi cluster that were
down-regulated in prostate tumors (Table S15) are the nuclear
Figure 4. A model of the profiles of fetal PSC and adult PSC
indicating commonalities and differences and the manner by
which these may alter in proliferative prostatic diseases.
Common and distinctive signaling pathways as well as molecules
participating in the regulation of self-renewal in fetal PSC and in
quiescence in adult PSC were revealed by our gene profiling studies.
The unbalanced scales represent possible perturbations in adult PSC
that result in the overexpression of certain proto-oncogenes that
promote SC self-renewal while other elements that promote differen-
tiation are suppressed, thus leading to deregulated growth. The
indicated candidate genes were detected as PSC-related genes that are
aberrantly expressed in prostate tumors. Their expression may
contribute to the etiology of abnormal PSC proliferation leading to
escape from dormancy and unrestrained self-renewal culminating in
benign prostate hyperplasia or prostate tumors.
doi:10.1371/journal.pone.0005722.g004
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a tumor suppressor in the prostate [73], and Parvb that is decreased
in esophageal cancer and may be involved in dedifferentiation and
metastasis [74]. Of the genes expressed in the Sca-1
Hi-only cluster,
(Table S15) Malat1, that is associated with endometrial stromal
sarcoma, was up-regulated [75]. Btg2, which promotes cell
quiescence and may be a tumor suppressor in prostate cells [76],
was down-regulated. One of the critical events in the development
of prostate tumors is gene fusion between the androgen-regulated
gene, TMPRSS2, and the ETS transcription factor family member
ERG [77]. Interestingly, we find that expression of both Erg (8-fold)
and Tmprss2 (3-fold) was up-regulated in the APSC. The
transcription factor Erg is essential for definitive hematopoiesis
and the function of normal adult hematopoietic stem cells [78],
therefore this molecule has an important role in normal stem cell
biology as well as in the promotion of tumorigenesis. Thus, our
profiling suggests that the aberrant regulation of certain PSC-
related genes may promote the progression of human prostate
tumors. In many instances genes that act as tumor suppressors and
differentiation inducers were down-regulated, while genes that
promote cellular proliferation were elevated in prostate tumors
(Figure 4).
Conclusion
In conclusion, based on the complementary findings of
functional and transcriptional analyses, the cohort of genes that
are active in the FPSC population are largely involved in self-
renewal, as would be expected in a proliferating fetal SC
population, while adult stem cells have a quiescent signature.
The proliferative fetal phenotype may be replicated during the
carcinogenic process resulting in the expansion of primitive cells
by activating pathways that promote the self-renewal of FPSC.
Thus, normally dormant APSC may acquire characteristics of self-
renewing primitive fetal prostate cells during oncogenesis
(Figure 4). Notably, prostate tumors have been shown to
originate in the stem cell enriched Sca-1
Hi expressing proximal
region of ducts [79]. The cohort of stem-related genes that also
appear to be deregulated in prostate tumors (Table S15) may
represent targets for novel therapeutic strategies for treating
prostatic diseases. In addition, these molecules may identify a
subset of tumors with a more primitive and possibly a more
aggressive phenotype. It will be interesting to compare the PSC
signature with a large cohort of human prostate tumors as they
progress to determine genes that increase or decrease in
abundance. These studies may indicate that an alteration in the
equilibrium between proto-oncogene and tumor suppressor
expression in PSC may favor the evolution of prostate tumors
and may also predict their aggressiveness.
Supporting Information
Figure S1 A two-dimensional principal component analysis
mapping of gene expression data from four prostate cell
populations. Expression data from the ‘‘significant genes’’, used
in our analysis, were averaged and subjected to principal
component analysis (PCA) mapping. The pattern is indicative of
good separation of the four populations and reproducibility within
the replicate samples in each group. Colors are indicative of the
four sample groups.
Found at: doi:10.1371/journal.pone.0005722.s001 (3.75 MB TIF)
Table S1 Antibodies used for FACS analyses of SC antigens.
Details of all primary antibodies and concentrations used for
FACS analysis.
Found at: doi:10.1371/journal.pone.0005722.s002 (1.38 MB TIF)
Table S2 Transcripts significantly expressed in stem/progenitor
subsets. Lists of transcripts that were significantly highly expressed
in each of the subsets (UGE, Sca-1Hi, Sca-1Lo). The relative
expression values (LR) compared to the average expression values
of control samples (Sca-1Neg) are presented. Each folder contains
the data of a separate subset.
Found at: doi:10.1371/journal.pone.0005722.s003 (1.07 MB
XLS)
Table S3 Transcripts significantly expressed in stem/progenitor
clusters. Lists of transcripts that were significantly highly expressed
in each of the clusters (UGE-only, UGE+Sca-1Hi, Sca-1Hi-only,
Sca-1Hi+Sca-1Lo). The relative expression values (LR) compared
to the average expression values of control samples (Sca-1Neg) are
presented. Each folder contains the data of a separate cluster.
Found at: doi:10.1371/journal.pone.0005722.s004 (0.92 MB
XLS)
Table S4 Markers currently described as being expressed in
primitive prostate cells and housekeeping genes. The upper half of
the table presents transcripts of known prostate stem cell markers
that were significantly highly expressed in the stem/progenitor
subsets. The lower half of the table presents transcripts of known
housekeeping genes and indicates that their expression was not
altered between the subsets.
Found at: doi:10.1371/journal.pone.0005722.s005 (0.04 MB
XLS)
Table S5 Markers currently described as being expressed in SC
populations. A list of transcripts previously described as being
expressed in stem cell populations that were significantly highly
expressed in each of the stem/progenitor-related subsets (UGE,
Sca-1Hi, Sca-1Lo). The relative expression values (LR) compared
to the average expression values of control samples (Sca-1Neg) are
presented.
Found at: doi:10.1371/journal.pone.0005722.s006 (0.08 MB
XLS)
Table S6 Comparisons of the PSC profile with five other
published SC profiles. Lists of transcripts that were significantly
highly expressed in each of the clusters (UGE-only, UGE+Sca-
1Hi, Sca-1Hi-only, Sca-1Hi+Sca-1Lo) and also known to have
elevated expression level in stem cells from other tissues. Each
folder presents highly expressed transcripts from a relevant cluster
that were also overexpressed in stem cells from another source, as
indicated.
Found at: doi:10.1371/journal.pone.0005722.s007 (0.74 MB
XLS)
Table S7 Gene ontology analysis indicating overrepresented
functional categories within gene clusters. Enriched functional
categories (P#0.001, after correction for multiple testing) were
identified in each of the stem/progenitor clusters.
Found at: doi:10.1371/journal.pone.0005722.s008 (0.48 MB TIF)
Table S8 Functional analysis of stem/progenitor clusters. A list
of the genes associated with each of the enriched functional
categories that were identified for each of the clusters.
Found at: doi:10.1371/journal.pone.0005722.s009 (0.23 MB
XLS)
Table S9 Self-renewal genes that are up-regulated in UGE cells.
A list of genes whose elevated expression is associated with NSC
self-renewal [19] was compared with the list of significantly over-
expressed genes in UGE cells. The table represents those genes
that were mutually expressed.
Found at: doi:10.1371/journal.pone.0005722.s010 (0.10 MB
XLS)
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PLoS ONE | www.plosone.org 12 May 2009 | Volume 4 | Issue 5 | e5722Table S10 Wnt pathway and target genes that are up-regulated
in UGE cells. The table presents genes that based on the published
literature are known to be either participants or targets of the Wnt
pathway. Bolded fonts indicate elevated transcript expression.
Found at: doi:10.1371/journal.pone.0005722.s011 (0.11 MB
XLS)
Table S11 Comparison of gene expression in primitive prostate
cell populations as determined by quantitative PCR. qPCR
analysis of selected genes from functional categories that were
identified in primitive prostate cells. Transcript levels were
normalized to the expression of HPRT (housekeeping gene). Data
[mean6SD] are presented as the fold change of the expression of
each gene in UGE, Sca-1Hi or Sca-1Lo cells relative to its
expression in Sca-1Neg cells.
Found at: doi:10.1371/journal.pone.0005722.s012 (0.09 MB
PDF)
Table S12 Shh pathway and target genes that are up-regulated in
UGE and Sca-1Hi cells. The table presents genes that based on the
published literature are known to be either participants or targets of
the Shh pathway. Bolded fonts indicate elevated transcript
expression.
Found at: doi:10.1371/journal.pone.0005722.s013 (0.06 MB
XLS)
Table S13 Promoter sequence analysis of stem/progenitor
clusters. A list of the genes associated with each of the enriched
promoter motifs that were identified for the UGE-only,
UGE+Sca-1Hi and Sca-1Hi-only clusters.
Found at: doi:10.1371/journal.pone.0005722.s014 (0.14 MB
XLS)
Table S14 TGF-b target genes in stem/progenitor clusters. A)
This list of TGFb-target genes was obtained after analysis of the
supplementary Table 1 of Zavadil et al. (2001) Proc. Natl. Acad.
Sci. USA 98 (12), 6686–6691. (10.1073/pnas.111614398). It
includes genes that were up-regulated in at least one time point
(0.3, 1, 2, 4 hr) after exposure to TGF-b. We compared the list of
TGF-b-induced genes (Table A) with our data from three PSC
clusters. The genes that are shared are depicted in the following
tables: B) UGE-only, C) UGE+Sca-1Hi, D) Sca-1Hi-only.
Found at: doi:10.1371/journal.pone.0005722.s015 (0.28 MB
XLS)
Table S15 Human prostate cancer signature compared with the
murine PSC signature. Gene expression data generated by a screen
that compared normal human prostate specimens with primary
prostate tumors [60] were used for this analysis. Based on the two-
group t-test(p,0.05) wegenerated two listsofgenes that were(i)up-
or (ii) down- regulated in human prostate tumors. The up-regulated
murine PSC profiles were compared with these two lists of genes.
Each folder represents genes from a relevant PSC cluster that were
either up- or down- regulated in human prostate tumors
Found at: doi:10.1371/journal.pone.0005722.s016 (0.17 MB
XLS)
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